Covid-19 highlights need for stricter ESG oversight


Responses to the virus have shown that misleading instruments falsely claiming to contain ESG products must be regulated to prevent further market abuse

Unlock this article.

The content you are trying to view is exclusive to our subscribers.

To unlock this article:

Take a Free Trial or Login
We use cookies to provide a personalized site experience.
By continuing to use & browse the site you agree to our Privacy Policy.
I agree